NCT06114550

Brief Summary

The goal of this clinial trial study is to explore the effect of high or low intensity resistance training (LIRT) under similar training volume on change in serum levels of BDNF, IGF-1, VEGF, irisin, and plasma Hcy in young adults.The main questions it aims to answer are:

  1. 1.Whether high and low intensity will increase the serum levels of BDNF, IGF-1, VEGF, irisin, and reduce plasma Hcy.
  2. 2.whether a greater magnitude of change would be suffer in low intensity group when compared to high intensity group, as an effect of greater physiological adaptation produced by more repetitions required to complete.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 24, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 2, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

February 27, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2024

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 7, 2024

Completed
Last Updated

February 1, 2024

Status Verified

January 1, 2024

Enrollment Period

1 month

First QC Date

October 24, 2023

Last Update Submit

January 30, 2024

Conditions

Keywords

neurotrophic growth factorsIGF-1BDNFVEGFIrisinHcy

Outcome Measures

Primary Outcomes (7)

  • Rata of perceived exertion

    The rating of perceive exertion (RPE) questionnaire scale was applied to assess participants' subjective fatigue feeling throughout the training period.

    "0 minutes" "60 minutes" "90 minutes"

  • Blood lactate

    serum blood lactate

    "0 minutes" "60 minutes" "90 minutes"

  • BDNF

    regulators of neurogenesis

    "0 minutes" "60 minutes" "90 minutes"

  • IGF-1

    regulators of neurogenesis

    "0 minutes" "60 minutes" "90 minutes"

  • VEGF

    regulators of neurogenesis

    "0 minutes" "60 minutes" "90 minutes"

  • Irisin

    regulators of neurogenesis

    "0 minutes" "60 minutes" "90 minutes"

  • Hcy

    homocysteine (Hcy) increase with age and resulted in cognitive function decline through greater oxidative stress and vascular dysfunction

    "0 minutes" "60 minutes" "90 minutes"

Secondary Outcomes (2)

  • Reactive time

    "0 minutes" "60 minutes" "90 minutes"

  • Accuracy rate

    "0 minutes" "60 minutes" "90 minutes"

Study Arms (2)

High-intensity resistance training group (HIRT)

EXPERIMENTAL

All subjects were instructed to conduct HIRT consisted of 4-5 sets of 12 repetitions at 80%1RM, with 1-2 minutes rests between each set.

Other: High intensity resistance training

low-intensity resistance training group (LIRT)

EXPERIMENTAL

All subjects were instructed to conduct LIRT consisted of 4-5 sets of 24 repetitions at 40%1RM, with same period) in random order.

Other: Low intensity resistance training

Interventions

The HIRT protocol comprised five exercises (bench press, barbell back squat, deadlift, seated leg flexion, and reverse arm curl) at 80% of 1RM, and 4-5 sets of 12 repetitions with 1-2 minutes of rest period between sets for approximately 60 minutes.

High-intensity resistance training group (HIRT)

For LIRT protocol, which performed same training exercises as HIRT. The repetitions in the LIRT protocol were assessed using the following equation: 80% of 1RM lifting load (kg) ×repetitions (HIRT)/40% of 1RM to volition fatigue, with 1-2 minutes of rest period between sets. Therefore, the LIRT protocol completed 4-5 sets of 24 repetitions at 40% of 1RM for a total of 60 minutes.

low-intensity resistance training group (LIRT)

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • age between 18 to 30 years
  • no experiencing musculoskeletal disorders or sports injuries
  • had not participated any regular aerobic endurance or resistance training with in the previous half years
  • no smoking habit or intake alcohol and other medication (e.g., steroid hormone)
  • good general body condition without any chronic diseases (e.g., osteoarthritis, metabolic syndrome or arthritis)

You may not qualify if:

  • experiencing musculoskeletal disorders or sports injuries in recent 1 month
  • had regular resistance training exercise
  • intake any supplementary(drug and hormone)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • chongwen zuo, Doctoral

    Air Force Medical Center of Chinese PLA

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Chongwen Zuo, Doctoral

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctoral

Study Record Dates

First Submitted

October 24, 2023

First Posted

November 2, 2023

Study Start

February 27, 2024

Primary Completion

March 30, 2024

Study Completion

April 7, 2024

Last Updated

February 1, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will share

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher. First author should be contacted if someone wants to request the data from this study.

Shared Documents
SAP
Time Frame
When this study was published.
Access Criteria
Shall not be used for secondary analysis or repeated publication
More information